$571.86
0.38% yesterday
Nasdaq, Dec 24, 07:00 pm CET

Medpace Stock price

$571.86
-46.63 7.54% 1M
+256.58 81.38% 6M
+239.63 72.13% YTD
+229.17 66.87% 1Y
+359.13 168.82% 3Y
+432.72 311.00% 5Y
+544.07 1,957.79% 10Y
+544.07 1,957.79% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+2.16 0.38%

New AI Insights on Medpace Insights AI Insights on Medpace

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$16.1b
Enterprise Value
$15.8b
Net debt
positive
Cash
$285.4m
Shares outstanding
28.1m
Valuation (TTM | estimate)
P/E
38.1 | 37.9
P/S
6.8 | 6.3
EV/Sales
6.7 | 6.2
EV/FCF
23.4
P/B
54.9
Financial Health
Equity Ratio
39.3%
Return on Equity
49.0%
ROCE
108.1%
ROIC
73.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.4b | $2.6b
EBITDA
$535.5m | $563.8m
EBIT
$507.0m | $541.6m
Net Income
$433.0m | $424.2m
Free Cash Flow
$676.8m
Growth (TTM | estimate)
Revenue
13.9% | 21.4%
EBITDA
22.4% | 18.4%
EBIT
24.0% | 21.2%
Net Income
18.4% | 4.9%
Free Cash Flow
26.3%
Margin (TTM | estimate)
Gross
31.1%
EBITDA
22.7% | 22.0%
EBIT
21.5%
Net
18.4% | 16.6%
Free Cash Flow
28.7%
More
EPS
$15.0
FCF per Share
$24.1
Short interest
6.2%
Employees
6k
Rev per Employee
$360.0k
Show more

Is Medpace a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Medpace Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Medpace forecast:

1x Buy
6%
11x Hold
61%
6x Sell
33%

Analyst Opinions

18 Analysts have issued a Medpace forecast:

Buy
6%
Hold
61%
Sell
33%

Financial data from Medpace

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,358 2,358
14% 14%
100%
- Direct Costs 1,625 1,625
12% 12%
69%
734 734
19% 19%
31%
- Selling and Administrative Expenses 198 198
12% 12%
8%
- Research and Development Expense - -
-
-
536 536
22% 22%
23%
- Depreciation and Amortization 29 29
1% 1%
1%
EBIT (Operating Income) EBIT 507 507
24% 24%
21%
Net Profit 433 433
18% 18%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Medpace directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medpace Stock News

Positive
Seeking Alpha
28 days ago
A longtime holding in many of our small-cap funds, Shift4 is a U.S. company that provides payment processing solutions for hospitality, retail and e‑commerce businesses. Five-Star is an Indian company that provides small-business and mortgage loans to eligible borrowers to meet their business and personal needs. Modine has experienced substantial growth from its data-center business, which like...
Positive
Investors Business Daily
about one month ago
The S&P 500's TJX is among the five stocks to watch showing resilience in a tough market
Positive
The Motley Fool
2 months ago
Medpace's revenue growth was strong last quarter. The company is building up a backlog as the clinical trial sector recovers.
More Medpace News

Company Profile

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Head office United States
CEO August Troendle
Employees 5,900
Founded 1992
Website investor.medpace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today